Skip to main content
Premium Trial:

Request an Annual Quote

AlphaHelix Merges with Techtum Lab

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swedish firms AlphaHelix Molecular Diagnostics and Techtum Lab have merged in an all-stock deal.

Under the terms of the deal, AlphaHelix will issue about 29.4 million shares of its stock at a price of SEK6.8 million ($1 million) to Labkompaniet, which owned Techtum. After the deal is completed, Labkompaniet will own a little less than 64 percent of the new company and shareholders of AlphaHelix will own the balance.

In a statement, AlphaHelix said that the deal provides it with a "complete marketing and sales organization" built upon 20 years of selling qPCR products in Scandinavia.

Techtum Lab sells PCR instruments and consumables. AlphaHelix develops and markets qPCR instruments.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.